Attila Aszodi

Defective smooth muscle regulation in cGMP kinase I‐deficient mice

Regulation of smooth muscle contractility is essential for many important biological processes such as tissue perfusion, cardiovascular haemostasis and gastrointestinal motility. While an increase in calcium initiates smooth muscle contraction, relaxation can be induced by cGMP or cAMP. cGMP‐dependent protein kinase I (cGKI) has been suggested as a major mediator of the relaxant effects of both nucleotides. To study the biological role of cGKI and its postulated cross‐activation by cAMP, we inactivated the gene coding for cGKI in mice. Loss of cGKI abolishes nitric oxide (NO)/cGMP‐dependent relaxation of smooth muscle, resulting in severe vascular and intestinal dysfunctions. However, cGKI‐deficient smooth muscle responded normally to cAMP, indicating that cAMP and cGMP signal via independent pathways, with cGKI being the specific mediator of the NO/cGMP effects in murine smooth muscle.

Fibromodulin-null Mice Have Abnormal Collagen Fibrils, Tissue Organization, and Altered Lumican Deposition in Tendon

Fibromodulin is a member of a family of connective tissue glycoproteins/proteoglycans containing leucine-rich repeat motifs. Several members of this gene family bind to fibrillar collagens and are believed to function in the assembly of the collagen network in connective tissues. Here we show that mice lacking a functional fibromodulin gene exhibit an altered morphological phenotype in tail tendon with fewer and abnormal collagen fiber bundles. In fibromodulin-null animals virtually all collagen fiber bundles are disorganized and have an abnormal morphology. Also 10–20% of the bundles in heterozygous mice are similar to the abnormal bundles in fibromodulin-null tail tendon. Ultrastructural analysis of Achilles tendon from fibromodulin-null mice show collagen fibrils with irregular and rough outlines in cross-section. Morphometric analysis show that fibromodulin-null mice have on the average thinner fibrils than wild type animals as a result of a larger preponderance of very thin fibrils in an overall similar range of fibril diameters. Protein and RNA analyses show an approximately 4-fold increase in the content of lumican in fibromodulin-null as compared with wild type tail tendon, despite a decrease in lumican mRNA. These results demonstrate a role for fibromodulin in collagen fibrillogenesis and suggest that the orchestrated action of several leucine-rich repeat glycoproteins/proteoglycans influence the architecture of collagen matrices.

Intestinal Secretory Defects and Dwarfism in Mice Lacking cGMP-Dependent Protein Kinase II

Cyclic guanosine 3′,5′-monophosphate (cGMP)-dependent protein kinases (cGKs) mediate cellular signaling induced by nitric oxide and cGMP. Mice deficient in the type II cGK were resistant to Escherichia coli STa, an enterotoxin that stimulates cGMP accumulation and intestinal fluid secretion. The cGKII-deficient mice also developed dwarfism that was caused by a severe defect in endochondral ossification at the growth plates. These results indicate that cGKII plays a central role in diverse physiological processes.

The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function

The vasodilator‐stimulated phosphoprotein (VASP) is associated with actin filaments and focal adhesions, which form the interface between the cytoskeleton and the extracellular matrix. VASP is phosphorylated by both the cAMP‐ and cGMP‐dependent protein kinases in a variety of cells, including platelets and smooth muscle cells. Since both the cAMP and cGMP signalling cascades relax smooth muscle and inhibit platelet activation, it was speculated that VASP mediates these effects by modulating actin filament dynamics and integrin activation. To study the physiological relevance of VASP in these processes, we inactivated the VASP gene in mice. Adult VASP‐deficient mice had normal agonist‐induced contraction, and normal cAMP‐ and cGMP‐dependent relaxation of intestinal and vascular smooth muscle. In contrast, cAMP‐ and cGMP‐mediated inhibition of platelet aggregation was significantly reduced in the absence of VASP. Other cAMP‐ and cGMP‐dependent effects in platelets, such as inhibition of agonist‐induced increases in cytosolic calcium concentrations and granule secretion, were not dependent on the presence of VASP. Our data show that two different cyclic, nucleotide‐dependent mechanisms are operating during platelet activation: a VASP‐independent mechanism for inhibition of calcium mobilization and granule release and a VASP‐dependent mechanism for inhibition of platelet aggregation which may involve regulation of integrin function.

Early detection of aging cartilage and osteoarthritis in mice and patient samples using atomic force microscopy

The pathological changes in osteoarthritis--a degenerative joint disease prevalent among older people--start at the molecular scale and spread to the higher levels of the architecture of articular cartilage to cause progressive and irreversible structural and functional damage. At present, there are no treatments to cure or attenuate the degradation of cartilage. Early detection and the ability to monitor the progression of osteoarthritis are therefore important for developing effective therapies. Here, we show that indentation-type atomic force microscopy can monitor age-related morphological and biomechanical changes in the hips of normal and osteoarthritic mice. Early damage in the cartilage of osteoarthritic patients undergoing hip or knee replacements could similarly be detected using this method. Changes due to aging and osteoarthritis are clearly depicted at the nanometre scale well before morphological changes can be observed using current diagnostic methods. Indentation-type atomic force microscopy may potentially be developed into a minimally invasive arthroscopic tool to diagnose the early onset of osteoarthritis in situ.

Discoidin Domain Receptor 1 Tyrosine Kinase Has an Essential Role in Mammary Gland Development

ABSTRACT Various types of collagen have been identified as potential ligands for the two mammalian discoidin domain receptor tyrosine kinases, DDR1 and DDR2. Here, we used a recombinant fusion protein between the extracellular domain of DDR1 and alkaline phosphatase to detect specific receptor binding sites during mouse development. Major sites of DDR1-binding activity, indicative of ligand expression, were found in skeletal bones, the skin, and the urogenital tract. Ligand expression in the uterus during implantation and in the mammary gland during pregnancy colocalized with the expression of the DDR1 receptor. The generation of DDR1-null mice by gene targeting yielded homozygous mutant animals that were viable but smaller in size than control littermates. The majority of mutant females were unable to bear offspring due to a lack of proper blastocyst implantation into the uterine wall. When implantation did occur, the mutant females were unable to lactate. Histological analysis showed that the alveolar epithelium failed to secrete milk proteins into the lumen of the mammary gland. The lactational defect appears to be caused by hyperproliferation and abnormal branching of mammary ducts. These results suggest that DDR1 is a key mediator of the stromal-epithelial interaction during ductal morphogenesis in the mammary gland.

Lifeact mice for studying F-actin dynamics.

1. Richter, S.H., Garner, J.P. & Würbel, H. Nat. Methods 6, 257–261 (2009). 2. Beynen, A.C., Gärtner, K. & van Zutphen, L.F.M. in Principles of Laboratory Animal Science 2nd edn. (eds., van Zutphen, L.F.M., Baumans, V. & Beynen, A.C.) 103–110 (Elsevier, Amsterdam, 2003). 3. Würbel, H. Nat. Genet. 26, 263 (2000). 4. Crabbe, J.C., Wahlsten, D. & Dudek, B.C. Science 284, 1670–1672 (1999). 5. Paylor, R. Nat. Methods 6, 253–254 (2009). 6 . Larkin, J.E., Frank, B.C., Gavras, H. & Quackenbush, J. Nat. Methods 2, 337– 343 (2005). experiment standardization increased test sensitivity at the expense of reproducibility. To confirm this statistically, we used a GLM to compare the two experimental designs for the effect of the factor ‘experiment’ and of the ‘strain-by-experiment’ interaction term on the variance in behavioral measures (Supplementary Methods). As expected, ‘experiment’ had a significantly greater effect in the standardized design (F1,35 = 63.65, P < 0.001), indicating greater variation in the data between standardized experiments. As the effects of genotype and environment are rarely additive1,4, we also expected greater variation in strain differences between standardized experiments. Indeed, F ratios of the ‘strain-by-experiment’ interaction term were significantly lower in heterogenized experiments (F1,35 = 54.63, P < 0.001), confirming better reproducibility (Fig. 1d). To assess whether this was caused by heterogenization increasing within-experiment variation, thereby reducing between-experiment variation, we calculated the F ratio of the ‘strain-by-experiment’ term divided by the ‘strain-by-block’ term. These F ratios were significantly smaller in heterogenized experiments (F1,35 = 38.82, P < 0.001), confirming that heterogenization increased within-experiment variation relative to between-experiment variation (Fig. 2 and Supplementary Figs. 3 and 4). Moreover, in the heterogenized design this F ratio was nearly equal to 1 (t-test of the null hypothesis that F = 1: T35 = –1.12; nonsignificant), demonstrating that data for blocks between experiments differed no more than for blocks within experiments. Thus, systematic variation of only two factors was sufficient to mimic the range of differences between the replicate experiments, which guaranteed virtually perfect reproducibility. These findings empirically confirm that standardized experiments can generate spurious results by increasing test sensitivity at the expense of external validity1. However, even simple forms of heterogenization may render study populations sufficiently heterogeneous to guarantee robust results across the unavoidable variation between experiments. This has important implications for behavioral screening studies but may also apply to other areas of laboratory research that are fraught with poor reproducibility because of study-, siteand sample-specific idiosyncrasies6. 5,000

Integrin‐linked kinase regulates chondrocyte shape and proliferation

The interaction of chondrocytes with the extracellular‐matrix environment is mediated mainly by integrins. Ligated integrins are recruited to focal adhesions (FAs) together with scaffolding proteins and kinases, such as integrin‐linked kinase (Ilk). Ilk binds the cytoplasmic domain of β1‐, β2‐ and β3‐integrins and recruits adaptors and kinases, and is thought to stimulate downstream signalling events through phosphorylation of protein kinase B/Akt (Pkb/Akt) and glycogen synthase kinase 3‐β (GSK3‐β). Here, we show that mice with a chondrocyte‐specific disruption of the gene encoding Ilk develop chondrodysplasia, and die at birth due to respiratory distress. The chondrodysplasia was characterized by abnormal chondrocyte shape and decreased chondrocyte proliferation. In addition, Ilk‐deficient chondrocytes showed adhesion defects, failed to spread and formed fewer FAs and actin stress fibres. Surprisingly, phosphorylation of Pkb/Akt and GSK3‐β is unaffected in Ilk‐deficient chondrocytes. These findings suggest that Ilk regulates actin reorganization in chondrocytes and modulates chondrocyte growth independently of phosphorylation of Pkb/Akt and GSK3‐β.

Cartilage Oligomeric Matrix Protein-Deficient Mice Have Normal Skeletal Development

ABSTRACT Cartilage oligomeric matrix protein (COMP) belongs to the thrombospondin family and is a homopentamer primarily expressed in cartilage. Mutations in the COMP gene result in the autosomal dominant chondrodysplasias pseudoachondroplasia (PSACH) and some types of multiple epiphyseal dysplasia (MED), which are characterized by mild to severe short-limb dwarfism and early-onset osteoarthritis. We have generated COMP-null mice to study the role of COMP in vivo. These mice show no anatomical, histological, or ultrastructural abnormalities and show none of the clinical signs of PSACH or MED. Northern blot analysis and immunohistochemical analysis of cartilage indicate that the lack of COMP is not compensated for by any other member of the thrombospondin family. The results also show that the phenotype in PSACH/MED cartilage disorders is not caused by the reduced amount of COMP.

Loss of alpha 10 beta 1 integrin expression leads to moderate dysfunction of growth plate chondrocytes

Integrin α10β1 is a collagen-binding integrin expressed on chondrocytes. In order to unravel the role of the α10 integrin during development, we generated mice carrying a constitutive deletion of the α10 integrin gene. The mutant mice had a normal lifespan and were fertile but developed a growth retardation of the long bones. Analysis of the skeleton revealed defects in the growth plate after birth characterized by a disturbed columnar arrangement of chondrocytes, abnormal chondrocyte shape and reduced chondrocyte proliferation. Electron microscopy of growth plates from newborn mice revealed an increased number of apoptotic chondrocytes and reduced density of the collagen fibrillar network compared to these structures in control mice. These results demonstrate that integrin α10β1 plays a specific role in growth plate morphogenesis and function.